Tag | Content |
---|
EnhancerAtlas ID | HS149-00709 |
Organism | Homo sapiens |
Tissue/cell | NKC |
Coordinate | chr2:136995350-136997470 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
SPI1 | MA0080.4 | chr2:136996513-136996527 | CACTTCCTGTTTTT | - | 6.36 | ZNF263 | MA0528.1 | chr2:136996150-136996171 | GGAGGAGGTGGGGTGGGGGAG | + | 6.32 |
|
| Number of super-enhancer constituents: 7 | ID | Coordinate | Tissue/cell |
SE_09631 | chr2:136994962-136998523 | CD14 | SE_10274 | chr2:136994079-136998605 | CD19_Primary | SE_11065 | chr2:136993029-137000475 | CD20 | SE_35084 | chr2:136991573-136998521 | HeLa | SE_39801 | chr2:136995254-136997355 | Jurkat | SE_61425 | chr2:136945577-137039880 | Toledo | SE_62403 | chr2:136962507-137014815 | Tonsil |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 3 | Chromosome | Start | End |
chr2 | 136996318 | 136996892 | chr2 | 136995499 | 136997317 | chr2 | 136995840 | 136996132 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH02I136235 | chr2 | 136993037 | 136998458 |
|
Enhancer Sequence | AATCATTCAC TGGAATGTAA AGTTGAGTGT ATTCTGAGCT TTAATGGATC TGAAACATTT 60 CAGGAGAATA TCACGAAGTT CTGGAATCAT CATTTCAGCA TAGGACCTTA GAGTCCTGTT 120 CTGGTTGAAC CTCTTTATCC CAGAGGAGAA AAGATTCAGA GAGACAAAGA AGTTTCGCTT 180 AAGGCTCATG GTGAATATAG TTGCAGACAA TCAGTACAAA TGAAGAGGAG AGAGGGTCCT 240 GCTGAATACC TCATAAAGAC CAGAAACTAG ACCCTTTGCT TACTGTATTA TAACTCTTTG 300 AACAGATTCC CAGCTGAAAC CATCAGAAGA GATGATTGGA CTCACTGCTG AAACATCCAG 360 CAGTGTGGCC TAGCTTCAGG TAAAGATGGA TCCAGGAGTT TGGAATCAAA TCCTAAAGAC 420 AAAGTCTCTT TTTTTTCTCT GTGTTAATTG TGCTGCTTTC CTTTGTGTTG GTTTTAATTC 480 CCCAGCAGGT TCTGTCCACA TGGTAGCTTC TGGCAGCTGT TAAGATTTTG TGCTACCAGA 540 TTAGTAATTC CAGTTGATGA ACAGCTTATA TTTCCCAATA GTTCCAGCAG AATCTCAGGA 600 GTCATGTTTG TGGGCTCCAA AAGGGTAACT CCTGAATCAG TCAGTATGAC CAGGGGTTTG 660 CTGTCAGCAT CATGGGCCAA CTCAAATCAG CTGAGTGGAG ACTGAGAGTA GGGGAGGGGT 720 GGGCAAGGTG AACATGCTGT TACCTGGAGG AGGAATCATT GCCAGAAACA CTAGAGGGCC 780 ACTACTCTTA CGATGGGCAA GGAGGAGGTG GGGTGGGGGA GGGCCAGAGA TTTTCTTTCA 840 GGAGCTAAAT CCCAGGGCTT AGTAATGGTA TTTGGCCTTA AGCCTGCAAA TGGCACTTTC 900 ATCCAGCAAT ATAAGCCCTG AAGTTTTTCT CAGCTGCAGA GAAGAGGTTT CCAGGAGGGT 960 GTCAGTTTGG CCCTTGCTGG TGGCCTGGCC TCTGCTAAAC ATCTCGGCCG TGCTCCTCCA 1020 TTTTCTGGCC GTGATAAGGC ACCCCGCCAA GCATATCTCA GACAAATATC TGTATTGTTT 1080 GTGGTGTGAT TGTGACTTCC TGTCTTCCAA TTTAGTTTTC TGCCTTACTT TTCACTGTCT 1140 GGGTCATTTG ATACTACATC TGGCACTTCC TGTTTTTTAA GACTCTGACT CTAGTCATCT 1200 GACTGTAGAA AACAGAGGTC AACTTCTTCA TAAGTGATGC CAGCTTTAGT CACTTGTTTT 1260 GGTATACTAG TTGAGATTTG CGTAAGGAAA ATTGTCAGGT GTCTGCTGGT TTTCTTAGCC 1320 TCAGACACTT CCCTATTTAT AAGTTTTTGT TTTTCAGACA TTGGGACTTT CTCCCCCTTG 1380 TGTGGATGTG GTGGGAGTGG GTGATCTCTG CCCTGTCCCT ACAAATAATT CAACGGTGGT 1440 TCTCTCTCTC TTAAGGAGAA CTACCAGTCC CGTAGATGCA GCTCTAGAAT GAGGGTGCTT 1500 TGGGCATAAC AGGCTCAGCC ATCCTTCTGG TGTCTCGCCC TGTCTCCTTT CCCATCCTTG 1560 GGTTCACTTC TCTCCCTTTT TCTCTTCACT TCAAAAGTGG TTAGCTCCAG TTAAATACCT 1620 GGAGTTGGGA CAGCAGAAAA GCTGCTAAAT GCAGATTTGC TTTTTCTCAC TAAAGAAAGA 1680 GGAACATTTT AGTCACTAAT TTTCACTTCA TTTAACCTTT CTTTCCACAG AATGGCCTGA 1740 CTTTTGCTGG AAGGGGACAA AGCCCTAAGA CATTTATATC CATGAGTAGA ACATTTATGA 1800 TATCACTTAC ACAGCTTCCT GGCCTGAGCT TTTCCAGACT TAGCTTATAT TTTAGTCAAA 1860 GTAGAGGGAT GGATTTAAGG AATTGTCTAA GATAAGTGAG AAGAGAGGAC ATTTGTCCTA 1920 CCTAAAGGCA ATGGCAGCTT GTGGGTGTGG CGGGGGGAAT CTATAAAAAA CATCGAAACA 1980 GGCTGGGCAT GGTAGCTCAC GCCTGTAATC TGAGCACTTT GGGAGGCCAA GGTGGGCGGA 2040 TCACCTGAGG TCAGGATTTT AAGACCAGCT TGGCCAACAT GGTGAAACCC CATCTCTACT 2100 ATACAAAAAT TGGCCAGGCA 2120
|